Entry stageSeed, Series A
Check sizen/a
Leads roundsYes
FocusLife sciences
Latest fund$450M Fund XIV (2026)
Investing team12 peopleNo activity since Sep
Who you would pitch at Atlas Venture
12 people on the investing team, 6 of them partners who can make the call. Partners are listed first.
Bruce BoothPartnerFocus: novel medicines and therapeutic platforms.
David GrayzelPartnerFocus: novel therapeutics near first-in-human testing.
Jason RhodesPartnerHe has held leadership roles at Alnylam Pharmaceuticals and Epizyme, and was a founder and partner at Fidelity Biosciences.
Jean-Francois FormelaPartnerFocus: drug discovery technologies.
Kevin BittermanPartnerHe has founded several companies and serves on multiple boards.
Michael GladstonePartnerFocus: building new therapeutics companies.
Aimee RaleighPrincipalFocus: innovative therapies and new biology.
Maurizio FazioPrincipalFocus: translating science into therapeutics.
Jernej GodecPrincipalHe previously worked at Apple Tree Partners and co-founded Mifcor.
Julia PianSenior AssociateFocus: novel therapies.
Justin FengSenior AssociateInvests in novel therapeutics.
Stella PaffenholzSenior AssociateInvests in early-stage biotech companies.
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Before you pitch
Ownership target7-10%
Notable investments
Alnylam PharmaceuticalsExelixisIntellia TherapeuticsKymera TherapeuticsDyne TherapeuticsDisc MedicineReplimuneCogent Biosciences
In their words
Atlas Venture - We build breakthrough biotechnology companies.Thirty years at the leading-edge of medical innovation and we’re just getting started.atlasventure.com
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Atlas Venture is active
One email when this firm shows new activity. Nothing else.
Firms like Atlas Venture
On these lists
Seed life sciences investors in Massachusetts27Series A life sciences investors in Massachusetts22Seed investors in United States2836Series A investors in United States1790Seed life sciences investors186Series A life sciences investors167Seed investors in Massachusetts95Series A investors in Massachusetts69
Questions
What stage does Atlas Venture invest in?
Atlas Venture reports entry at seed, series a.
How much does Atlas Venture invest?
Atlas Venture has not reported a check size.
Does Atlas Venture lead rounds?
Yes. Atlas Venture says it can lead.
Who are the partners at Atlas Venture?
Bruce Booth (Partner), David Grayzel (Partner), Jason Rhodes (Partner), Jean-Francois Formela (Partner), Kevin Bitterman (Partner), Michael Gladstone (Partner).
Is Atlas Venture active right now?
No recent activity since September 2026.
Work at Atlas Venture? Claim or correct this profile.